Activated peritoneal cavity B-1a cells possess regulatory B cell properties.

PubWeight™: 0.82‹?›

🔗 View Article (PMC 3923827)

Published in PLoS One on February 13, 2014

Authors

Bram Margry1, Saskia C W Kersemakers1, Aad Hoek1, Ger J A Arkesteijn1, Willemien H Wieland1, Willem van Eden1, Femke Broere1

Author Affiliations

1: Department of Infectious Diseases and Immunology, Utrecht University, Utrecht, The Netherlands.

Articles cited by this

The regulation of IL-10 production by immune cells. Nat Rev Immunol (2010) 9.18

A regulatory B cell subset with a unique CD1dhiCD5+ phenotype controls T cell-dependent inflammatory responses. Immunity (2008) 6.73

CD19(+)CD24(hi)CD38(hi) B cells exhibit regulatory capacity in healthy individuals but are functionally impaired in systemic Lupus Erythematosus patients. Immunity (2010) 5.13

Characterization of a rare IL-10-competent B-cell subset in humans that parallels mouse regulatory B10 cells. Blood (2010) 4.28

Prevention of arthritis by interleukin 10-producing B cells. J Exp Med (2003) 4.27

The double life of a B-1 cell: self-reactivity selects for protective effector functions. Nat Rev Immunol (2010) 4.26

Immune regulatory function of B cells. Annu Rev Immunol (2012) 3.55

Regulatory B cells control T-cell autoimmunity through IL-21-dependent cognate interactions. Nature (2012) 3.48

Not always the bad guys: B cells as regulators of autoimmune pathology. Nat Rev Immunol (2008) 3.40

Novel suppressive function of transitional 2 B cells in experimental arthritis. J Immunol (2007) 3.09

B10 cells and regulatory B cells balance immune responses during inflammation, autoimmunity, and cancer. Ann N Y Acad Sci (2010) 3.07

The development and function of regulatory B cells expressing IL-10 (B10 cells) requires antigen receptor diversity and TLR signals. J Immunol (2009) 2.87

Regulatory B cells (B10 cells) and regulatory T cells have independent roles in controlling experimental autoimmune encephalomyelitis initiation and late-phase immunopathogenesis. J Immunol (2010) 2.44

B cell depletion therapy ameliorates autoimmune disease through ablation of IL-6-producing B cells. J Exp Med (2012) 2.36

Mice lacking endogenous IL-10-producing regulatory B cells develop exacerbated disease and present with an increased frequency of Th1/Th17 but a decrease in regulatory T cells. J Immunol (2011) 2.31

TLR-activated B cells suppress T cell-mediated autoimmunity. J Immunol (2008) 2.25

Regulatory B cells prevent and reverse allergic airway inflammation via FoxP3-positive T regulatory cells in a murine model. J Allergy Clin Immunol (2010) 2.15

CD19+CD24hiCD38hi B cells maintain regulatory T cells while limiting TH1 and TH17 differentiation. Sci Transl Med (2013) 1.89

Selective targeting of B cells with agonistic anti-CD40 is an efficacious strategy for the generation of induced regulatory T2-like B cells and for the suppression of lupus in MRL/lpr mice. J Immunol (2009) 1.87

Apoptotic cells protect mice from autoimmune inflammation by the induction of regulatory B cells. Proc Natl Acad Sci U S A (2007) 1.86

Division and differentiation of natural antibody-producing cells in mouse spleen. Proc Natl Acad Sci U S A (2007) 1.82

Novel function of B cell-activating factor in the induction of IL-10-producing regulatory B cells. J Immunol (2010) 1.57

Regulatory B cell production of IL-10 inhibits lymphoma depletion during CD20 immunotherapy in mice. J Clin Invest (2011) 1.50

Interleukin-10 produced by B cells is crucial for the suppression of Th17/Th1 responses, induction of T regulatory type 1 cells and reduction of collagen-induced arthritis. Arthritis Res Ther (2012) 1.39

Expression of CD80/86 on B cells is essential for autoreactive T cell activation and the development of arthritis. J Immunol (2007) 1.28

Chronic lymphocytic leukemia and regulatory B cells share IL-10 competence and immunosuppressive function. Leukemia (2012) 1.26

Regulatory role of B-1 B cells in chronic colitis. Int Immunol (2008) 1.25

Accumulation of splenic B1a cells with potent antigen-presenting capability in NZM2410 lupus-prone mice. Arthritis Rheum (1998) 1.20

Schistosomes induce regulatory features in human and mouse CD1d(hi) B cells: inhibition of allergic inflammation by IL-10 and regulatory T cells. PLoS One (2012) 1.15

Innate responses of B cells. Eur J Immunol (2007) 1.15

A tolerogenic role for Toll-like receptor 9 is revealed by B-cell interaction with DNA complexes expressed on apoptotic cells. Proc Natl Acad Sci U S A (2011) 1.14

Amplified B lymphocyte CD40 signaling drives regulatory B10 cell expansion in mice. PLoS One (2011) 1.13

Peritoneal cavity regulatory B cells (B10 cells) modulate IFN-γ+CD4+ T cell numbers during colitis development in mice. J Immunol (2013) 1.12

Roles of B-1 and B-2 cells in innate and acquired IgA-mediated immunity. Immunol Rev (2010) 1.12

B-1 cell (CD5+B220+) outgrowth in murine schistosomiasis is genetically restricted and is largely due to activation by polylactosamine sugars. J Immunol (1997) 1.07

CD22 expression mediates the regulatory functions of peritoneal B-1a cells during the remission phase of contact hypersensitivity reactions. J Immunol (2010) 0.94

Activated T cells induce rapid CD83 expression on B cells by engagement of CD40. Immunol Lett (2011) 0.86

Peritoneal cavity B-1a cells promote peripheral CD4+ T-cell activation. Eur J Immunol (2013) 0.82

Protective autoantibodies in the rheumatic diseases: lessons for therapy. Nat Rev Rheumatol (2013) 0.81

Different inflammatory stimuli in the footpad of mice influence the kinetics of resident peritoneal cells. Inflamm Res (2012) 0.79

Constitutively CD40-activated B cells regulate CD8 T cell inflammatory response by IL-10 induction. J Immunol (2013) 0.79